Corporate Banner
Satellite Banner
Technology Networks Header
Monday, September 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
BD Introduces New Automated Erythrocyte Sedimentation Rate Instrument
Wednesday, December 11, 2013
BD Sedi-20 & BD Sedi-40 help improve accuracy and patient outcomes.

A Hint to Find Rapid Test Kits for Diagnostic and Research Uses
Wednesday, December 04, 2013
The constant concerns on food, production processes, specific analytical food parameters, detection of diseases etc. are the main reasons that prompt the advances in rapid test kits, as the economic theory shows “where there is need, where there is market”.

EKF HbA1c Analyzer Assessment Success Presented at World Diabetes Congress
Wednesday, December 04, 2013
Swansea University, College of Medicine, presents scientific poster at IDF 2013.

EKF Launches POC Lactate Analyzer with Hematocrit Compensation
Wednesday, December 04, 2013
Built-in hematocrit compensation delivers high accuracy lactate analysis.

Enhanced General Purpose Centrifuge Product Line Increases Capacity and Flexibility
Tuesday, December 03, 2013
New enhanced general purpose centrifuge product line offers clinical and life science researchers the ability to spin more samples in a single run while maximizing critical lab space.

VolitionRx Finds Simple Blood Test Detects 85% of Colorectal Cancers and Over 50% of Polyps
Monday, December 02, 2013
The new findings come from its ongoing prospective study with CHU Dinant Godinne | UCL Namur Hospital in Belgium.

Bio-Rad Launches CFX Manager™ Software for Real-Time PCR
Wednesday, November 27, 2013
The software allows users to quickly and easily set up a real-time PCR experiment, assess data quality, and interpret results.

AB SCIEX Launches CE Marked IVD-MS™ Analyzer for Hospitals and Diagnostic Laboratories in Europe
Tuesday, November 26, 2013
The first-in-class, complete analyzer is based on LC/MS/MS technology meeting European regulatory requirements.

Microbiologics Debuts New Molecular Standards Product Line - Helix Elite™
Tuesday, November 19, 2013
Company unveils Helix Elite™ at the Association for Molecular Pathology’s Annual Meeting in Phoenix.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 455
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv